ArticleInfection and drug resistance2018
Multicenter prospective study on the prevalence of colistin resistance in
Article in Infection and drug resistance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 23 citations in OpenAlex.
- Harnessing CRISPR interference to resensitize laboratory strains and clinical isolates to last resort antibiotics.Scientific reports · 2025Article
- Detection ofMicroorganisms · 2024Article
- Worldwide Prevalence ofPathogens (Basel, Switzerland) · 2022Review
- Genomic Characterization of VIM and MCR Co-Producers: The First Two Clinical Cases, in Italy.Diagnostics (Basel, Switzerland) · 2021Article
- Genomic Characterization ofFrontiers in microbiology · 2021Article
- Emergence of a multidrug-resistant ST 27 Escherichia coli co-harboring blaThe Journal of antibiotics · 2020Article
- Bloodstream infections caused by Escherichia coli carrying mcr-1 gene in hospitalized patients in northern Italy from 2012 to 2018.Infection · 2020Article
- Article
- Gastrointestinal colonization with multidrug-resistant Gram-negative bacteria during extracorporeal membrane oxygenation: effect on the risk of subsequent infections and impact on patient outcome.Annals of intensive care · 2019Article
- Using Colistin as a Trojan Horse: Inactivation of Gram-Negative Bacteria with Chlorophyllin.Antibiotics (Basel, Switzerland) · 2019Article
- Colistin-resistant Escherichia coli with mcr genes in the livestock of rural small-scale farms in Ecuador.BMC research notes · 2019Article
- Detection ofAntimicrobial agents and chemotherapy · 2019Article
- The Microbiological Characteristics of Carbapenem-ResistantJournal of clinical medicine · 2019Article
- Emergence of a novel mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella pneumoniae.Emerging microbes & infections · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 8 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe emergence of the plasmid-mediated colistin resistance mechanism in MATERIALS AND
methodsA prospective study was performed during a 4-month period (May to August, 2016) in six acute care Hospitals. Consecutive nonduplicate clinical isolates of
resultsOverall, 3,902 consecutive
conclusionResistance to colistin in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.